ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013

RFA On Pathology Training Released

February 1, 1980

In Brief: Interim Money Bill Passes; NCI Can Start Awarding Grants, Contract With 1980 funds, Until Nov. 20

October 26, 1979

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

NCI New Advisory Group Named On special Populations

June 25, 1999

Cooperative Groups Not Included Among Grants to Be Funded At Recommended Levels

November 11, 1983